OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
Ying Tian, Eri Arai, Satomi Makiuchi, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2461-2477
Open Access | Times Cited: 44
Ying Tian, Eri Arai, Satomi Makiuchi, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2461-2477
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 45
DNA Methylation in Nonalcoholic Fatty Liver Disease
Jeongeun Hyun, Youngmi Jung
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8138-8138
Open Access | Times Cited: 83
Jeongeun Hyun, Youngmi Jung
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8138-8138
Open Access | Times Cited: 83
Current Options and Future Directions for NAFLD and NASH Treatment
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7571-7571
Open Access | Times Cited: 76
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7571-7571
Open Access | Times Cited: 76
Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
Stephanie Talamantes, Michela Lisjak, Eduardo Hideo Gilglioni, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100811-100811
Open Access | Times Cited: 28
Stephanie Talamantes, Michela Lisjak, Eduardo Hideo Gilglioni, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100811-100811
Open Access | Times Cited: 28
DNA methylation markers in the detection of hepatocellular carcinoma
Siyu Fu, José D. Debes, André Boonstra
European Journal of Cancer (2023) Vol. 191, pp. 112960-112960
Open Access | Times Cited: 25
Siyu Fu, José D. Debes, André Boonstra
European Journal of Cancer (2023) Vol. 191, pp. 112960-112960
Open Access | Times Cited: 25
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer
Yiyang Wang, Yongxiang Li, Yubo Jing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Yiyang Wang, Yongxiang Li, Yubo Jing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Epigenetic modifications in obesity‐associated diseases
Yiqian Long, Chao Mao, Shuang Liu, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 10
Yiqian Long, Chao Mao, Shuang Liu, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 10
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1774-1789.e8
Closed Access | Times Cited: 10
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1774-1789.e8
Closed Access | Times Cited: 10
Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy
Xinyao Hu, Hua Zhu, Biao Chen, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 858-858
Open Access | Times Cited: 25
Xinyao Hu, Hua Zhu, Biao Chen, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 858-858
Open Access | Times Cited: 25
DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies
Emanuel Gonçalves, Maria Gonçalves-Reis, José B. Pereira‐Leal, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Emanuel Gonçalves, Maria Gonçalves-Reis, José B. Pereira‐Leal, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Yutaka Endo, Henrique A. Lima, Laura Alaimo, et al.
HPB (2023) Vol. 25, Iss. 3, pp. 353-362
Open Access | Times Cited: 16
Yutaka Endo, Henrique A. Lima, Laura Alaimo, et al.
HPB (2023) Vol. 25, Iss. 3, pp. 353-362
Open Access | Times Cited: 16
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11119-e11119
Open Access | Times Cited: 20
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11119-e11119
Open Access | Times Cited: 20
Molecular pathological approach to cancer epigenomics and its clinical application
Yae Kanai
Pathology International (2024) Vol. 74, Iss. 4, pp. 167-186
Open Access | Times Cited: 4
Yae Kanai
Pathology International (2024) Vol. 74, Iss. 4, pp. 167-186
Open Access | Times Cited: 4
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 4
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 4
Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma
Zelin Tian, Xu Chen, Peijun Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Zelin Tian, Xu Chen, Peijun Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
DNA Methylation Profile in Buffy Coat Identifies Methylation Differences Between Cirrhosis with and Without Hepatocellular Carcinoma
Hyeyeun Lim, Hashem B. El–Serag, Michelle Luster, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 266-266
Open Access
Hyeyeun Lim, Hashem B. El–Serag, Michelle Luster, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 266-266
Open Access
Genome-wide DNA methylation markers associated with metabolic liver cancer
Samuel O. Antwi, Ampem Darko Jnr Siaw, Sebastian M. Armasu, et al.
Gastro Hep Advances (2025) Vol. 4, Iss. 5, pp. 100621-100621
Open Access
Samuel O. Antwi, Ampem Darko Jnr Siaw, Sebastian M. Armasu, et al.
Gastro Hep Advances (2025) Vol. 4, Iss. 5, pp. 100621-100621
Open Access
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease
Junjie Wang, Xiaohong Chen, Yirong Zhang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Junjie Wang, Xiaohong Chen, Yirong Zhang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary urothelial carcinomas
Koji Tsumura, Mao Fujimoto, Ying Tian, et al.
Experimental and Molecular Pathology (2024) Vol. 137, pp. 104908-104908
Open Access | Times Cited: 3
Koji Tsumura, Mao Fujimoto, Ying Tian, et al.
Experimental and Molecular Pathology (2024) Vol. 137, pp. 104908-104908
Open Access | Times Cited: 3
Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis
Junko Kuramoto, Eri Arai, Mao Fujimoto, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Junko Kuramoto, Eri Arai, Mao Fujimoto, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma
Yutaka Endo, Zorays Moazzam, Laura Alaimo, et al.
HPB (2023) Vol. 25, Iss. 12, pp. 1484-1493
Closed Access | Times Cited: 6
Yutaka Endo, Zorays Moazzam, Laura Alaimo, et al.
HPB (2023) Vol. 25, Iss. 12, pp. 1484-1493
Closed Access | Times Cited: 6
Signal Transduction and Molecular Regulation in Fatty Liver Disease
X. Charlie Dong, Kushan Chowdhury, Menghao Huang, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 9, pp. 689-717
Open Access | Times Cited: 12
X. Charlie Dong, Kushan Chowdhury, Menghao Huang, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 9, pp. 689-717
Open Access | Times Cited: 12
Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics
Xiaofei Peng, Shifeng Huang, Lingjuan Chen, et al.
Pharmacological Research (2021) Vol. 172, pp. 105846-105846
Closed Access | Times Cited: 12
Xiaofei Peng, Shifeng Huang, Lingjuan Chen, et al.
Pharmacological Research (2021) Vol. 172, pp. 105846-105846
Closed Access | Times Cited: 12
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3257-3257
Open Access | Times Cited: 12
Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3257-3257
Open Access | Times Cited: 12
